NovaBridge Biosciences
NBP
$3.89
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.81M | 3.82M | 7.34M | 7.34M | 7.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.99M | 7.11M | 13.37M | 13.37M | 12.41M |
| Operating Income | -8.99M | -7.11M | -13.37M | -13.37M | -12.41M |
| Income Before Tax | -6.83M | -5.50M | -10.84M | -10.84M | -20.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.83M | -5.50M | -10.84M | -10.84M | -20.49M |
| Earnings from Discontinued Operations | -- | -- | 1.78M | 1.78M | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.83M | -5.50M | -9.06M | -9.06M | -20.49M |
| EBIT | -8.99M | -7.11M | -13.37M | -13.37M | -12.41M |
| EBITDA | -8.97M | -7.10M | -13.31M | -13.31M | -12.39M |
| EPS Basic | -0.15 | -0.16 | -0.26 | -0.26 | -0.58 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.07 | -0.07 | -0.05 |
| EPS Diluted | -0.15 | -0.16 | -0.26 | -0.26 | -0.58 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.07 | -0.07 | -0.05 |
| Average Basic Shares Outstanding | 104.21M | 81.70M | 81.50M | 81.50M | 81.50M |
| Average Diluted Shares Outstanding | 45.31M | 35.52M | 35.44M | 35.44M | 35.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |